Price
Target price
€0.025
€0.025
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Navco Pharmaceuticals Inc.
sharewise wants to provide you with the best news and tools for Navco Pharmaceuticals Inc., so we directly link to the best financial data sources.
Financials
News
Navco Readies Launch of Antimicrobial Line
Next Generation Antimicrobial Line Readies for Commercial Launch
Vancouver, British Columbia--(June 4, 2024) - Navco Pharmaceuticals Inc. (TSXV: NAV) (“Navco” or the “Company”), is now
